Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Elderberry Ventures is a Swedish venture studio and investment firm dedicated to the creation and growth of innovative life science companies. Based in Malmö, the firm was founded by Peter Benson, a prominent figure in the Nordic biotech investment community, to bridge the gap between academic breakthroughs and commercial success. Elderberry Ventures takes an active, hands-on role in its portfolio companies, often providing the initial management team and strategic direction. Its current focus includes advanced modalities such as in vivo cell reprogramming and complement-based immunotherapies. By leveraging a deep network within the Scandinavian life science ecosystem, the firm identifies high-potential scientific innovations and transforms them into viable biotech entities. Elderberry Ventures primarily targets therapeutic areas with significant unmet needs, particularly in oncology and immunology.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Elderberry Ventures.